Structural and binding studies of cyclin‐dependent kinase 2 with NU6140 inhibitor
Author:
Affiliation:
1. Aurigene Discovery Technologies Ltd Bangalore India
2. School of Basic and Applied Sciences Dayananda Sagar University Bangalore India
Publisher
Wiley
Subject
Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.13941
Reference50 articles.
1. ICM?A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation
2. Phase II study of flavopiridol in patients with advanced colorectal cancer
3. Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma
4. Treatment of Relapsed Chronic Lymphocytic Leukemia by 72-Hour Continuous Infusion or 1-Hour Bolus Infusion of Flavopiridol: Results from Cancer and Leukemia Group B Study 19805
5. Flavopiridol induces G1 arrest with inhibition of cyclin‐dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells;Carlson B. A.;Cancer Research,1996
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3